Accredited Wealth Management LLC purchased a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the 4th quarter, HoldingsChannel.com reports. The fund purchased 795 shares of the exchange traded fund’s stock, valued at approximately $72,000.
A number of other institutional investors have also added to or reduced their stakes in XBI. Mercer Global Advisors Inc. ADV lifted its holdings in shares of SPDR S&P Biotech ETF by 14.9% during the fourth quarter. Mercer Global Advisors Inc. ADV now owns 12,740 shares of the exchange traded fund’s stock valued at $1,147,000 after purchasing an additional 1,651 shares during the last quarter. BlueCrest Capital Management Ltd bought a new position in SPDR S&P Biotech ETF during the 4th quarter valued at approximately $138,051,000. RA Capital Management L.P. purchased a new position in SPDR S&P Biotech ETF during the fourth quarter valued at $110,615,000. Itau Unibanco Holding S.A. bought a new stake in SPDR S&P Biotech ETF in the fourth quarter worth $1,173,000. Finally, Rehmann Capital Advisory Group boosted its holdings in SPDR S&P Biotech ETF by 7.0% in the fourth quarter. Rehmann Capital Advisory Group now owns 5,291 shares of the exchange traded fund’s stock worth $477,000 after acquiring an additional 345 shares in the last quarter.
SPDR S&P Biotech ETF Price Performance
Shares of NYSEARCA:XBI opened at $83.50 on Friday. The business has a fifty day moving average price of $81.66 and a 200-day moving average price of $89.92. The company has a market capitalization of $5.30 billion, a PE ratio of 11.47 and a beta of 1.00. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $105.47.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Read More
- Five stocks we like better than SPDR S&P Biotech ETF
- What is the Dogs of the Dow Strategy? Overview and Examples
- Magnificent 7 Stocks Send a Dire Warning to Markets
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Why Spotify Stock Still Has Room to Run in 2025
- Insider Trades May Not Tell You What You Think
- Buy the Dip: Top Tech Stocks Analysts Say Are Undervalued
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.